protein energy malnutrition: A nutritional deficit that is caused by inadequate protein or calorie intake.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
209 |
4. Check minimum number of eventsNone |
209 |
5. Include endpointsNone |
209 |
6. Filter based on genotype QC (FinnGen only) |
198 |
Control definitions (FinnGen only)
- Control exclude
- E4_MALNUTRITION
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E40-E46
- Name in latin
- Malnutritio non specificata ex deficientia proteino-energetica
Unspecified protein-energy malnutrition
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2837 | 1661 | 1166 |
| Only index persons | 2520 | 1510 | 1010 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.03 |
| Only index persons | 0.05 | 0.06 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 75.04 | 77.51 | 71.59 |
| Only index persons | 75.85 | 78.14 | 72.43 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 198 | 110 | 88 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 72.91 | 69.94 | 76.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 209
- Matched controls
- 2090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E46
ICD-10 Finland
Unspecified protein-energy malnutrition
+∞
285.6
203
*
E86
ICD-10 Finland
Volume depletion
18.1
40.9
35
23
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
9.5
21.5
27
32
A28
ICPC
Limited function/disability NOS
3.9
19.2
80
287
R63.4
ICD-10 Finland
Abnormal weight loss
7.6
17.9
27
40
E87.6
ICD-10 Finland
Hypokalaemia
7.6
16.1
24
35
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
16.0
75
286
SPAT1229
SPAT
Assessment of need for aid
5.0
15.3
37
87
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.0
15.2
36
83
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.1
14.3
105
517
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.4
14.0
30
63
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.4
13.6
63
236
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
12.7
89
421
L28
ICPC
Limited function/disability (L)
3.2
12.7
68
277
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.4
12.5
22
38
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
12.4
89
426
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.6
12.1
24
47
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
10.9
36
107
D64.9
ICD-10 Finland
Anaemia, unspecified
3.4
10.4
44
154
AA1AD
NOMESCO Finland
CT of head and brain
2.7
10.4
80
391
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.2
10.2
29
77
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
9.6
26
66
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
9.5
32
96
Z51.5
ICD-10 Finland
Palliative care
3.8
9.5
31
91
I95.1
ICD-10 Finland
Orthostatic hypotension
4.7
9.4
23
54
Z25.1
ICD-10 Finland
Need for immunization against influenza
5.0
9.3
21
46
ZXD05
NOMESCO Finland
Urgent procedure
2.6
9.3
78
394
R53
ICD-10 Finland
Malaise and fatigue
2.5
9.1
78
397
JN4AD
NOMESCO Finland
Body CT examination
3.7
9.0
31
94
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
7.8
9.0
20
28
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
8.9
41
150
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
8.5
40
148
R5110, ,
SPAT
3.9
8.4
26
73
C03CA01
ATC
furosemide; systemic
2.4
8.4
102
603
N05AX08
ATC
risperidone; systemic
3.1
8.2
38
139
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
8.2
50
214
JDB10
NOMESCO Finland
Percutaneous gastrostomy
18.1
8.2
12
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
8.0
51
223
A46
ICD-10 Finland
Erysipelas
2.8
7.5
43
177
EBA15
NOMESCO Finland
Extraction of multiple teeth
7.3
7.5
17
25
F03
ICD-10 Finland
Unspecified dementia
4.0
7.4
22
60
SPAT1216
SPAT
Assessment of functional ability
2.6
7.4
53
245
S97
ICPC
Chronic ulcer skin
3.6
7.4
26
80
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
+∞
7.3
7
*
SPAT1301
SPAT
No procedures
2.3
7.3
82
463
K59.09
ICD-10 Finland
Constipation, unspecified
3.5
7.3
26
81
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.6
7.1
13
13
SPAT1254
SPAT
Administration of medicine
2.6
7.0
48
217
N02AA05
ATC
oxycodone; systemic
2.4
6.9
57
280
L89
ICD-10 Finland
Decubitus ulcer and pressure area
8.7
6.9
14
17
R4110
NOMESCO Finland
Physiotherapy
2.2
6.8
74
410
B03BA03
ATC
hydroxocobalamin; parenteral
3.5
6.7
24
75
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.9
6.7
20
55
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.7
6.6
18
34
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
6.6
54
264
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
6.5
32
121
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
6.5
52
252
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
6.4
48
225
W19
ICD-10 Finland
Unspecified fall
2.8
6.4
34
134
SPAT1255
SPAT
Intravenous administration of medicine
3.6
6.2
21
63
WX892
NOMESCO Finland
Monitored bed care
3.4
6.1
22
69
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.5
6.0
21
64
Z2446
NOMESCO Finland
Social worker
3.3
6.0
24
80
JN4CD
NOMESCO Finland
Very extensive body CT
5.3
6.0
17
34
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
6.0
55
282
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
93
263
5.57
32.76
7.7
4.3
0.77
0.81
mmol/l
1.97
88
244
157
716
5.79
30.03
8.8
4.7
29.69
35.10
g/l
15.66
152
663
79
232
4.87
25.78
3.1
2.4
17.72
22.30
%
1.74
69
192
110
452
4.03
22.21
3.0
2.4
3.54
3.06
mg/l
0.60
101
381
115
498
3.91
21.28
3.8
2.4
53.22
55.61
u/l
0.34
109
462
155
838
4.29
20.29
11.4
7.4
1.20
1.22
mmol/l
2.20
129
711
147
773
4.04
19.89
8.1
7.0
1.20
1.22
mmol/l
2.28
138
695
134
665
3.83
19.74
3.5
2.5
72.98
78.51
nmol/l
1.23
127
578
90
345
3.83
19.66
2.4
1.8
1301.69
1159.60
nmol/l
0.75
69
255
118
577
3.40
17.02
4.6
3.1
2.29
2.36
mmol/l
2.89
109
503
130
678
3.43
16.78
2.8
2.0
78.44
95.88
pmol/l
3.97
80
322
48
136
4.28
15.72
2.4
1.7
—
—
—
0
0
25
42
6.63
14.69
1.5
1.6
—
—
—
0
0
137
783
3.18
14.30
27.3
16.4
1.30
1.29
inr
0.03
46
221
56
189
3.68
14.25
2.9
4.0
254.75
240.74
u/l
0.32
51
178
124
678
3.04
13.87
3.8
2.8
218.43
116.16
ug/l
2.00
115
603
42
124
3.99
12.87
3.1
5.4
2.45
1.88
mmol/l
0.38
28
88
22
39
6.19
12.23
1.4
1.5
210.46
284.32
ug/g
0.84
13
25
104
545
2.81
12.13
5.5
3.4
447.50
168.35
e6/l
0.31
89
416
27
59
5.11
12.04
1.4
1.3
—
—
—
0
0
90
440
2.84
11.96
5.5
4.7
0.00
0.00
estimate
-0.00
30
142
86
416
2.81
11.59
2.2
1.6
19.96
22.04
nmol/l
0.50
78
345
112
622
2.73
11.49
5.8
3.4
—
—
—
0
0
130
784
2.74
11.22
7.3
5.8
0.00
0.00
estimate
-0.00
32
146
113
637
2.68
11.16
6.4
4.4
48.67
50.23
ng/l
0.04
100
457
37
111
3.84
11.02
2.0
1.3
—
—
—
0
0
129
790
2.65
10.56
5.6
4.3
0.00
0.00
estimate
-0.00
31
141
108
608
2.61
10.52
6.1
4.6
—
—
—
0
0
128
782
2.64
10.51
5.4
4.3
0.00
0.00
estimate
-0.00
34
159
97
531
2.54
9.86
4.6
3.6
2614.59
1745.14
ng/l
0.83
90
444
62
272
2.82
9.84
6.0
3.2
5.81
2.89
e6/l
1.16
51
145
40
139
3.32
9.49
4.4
3.4
103.21
73.00
ng/l
0.77
33
123
92
499
2.51
9.44
3.7
2.1
213.13
267.06
u/l
0.30
87
470
74
364
2.60
9.31
1.9
1.8
450.76
482.98
pmol/l
0.35
55
297
41
148
3.20
9.13
6.2
4.0
—
—
—
0
0
51
212
2.86
8.87
8.5
8.2
102.02
104.18
mmol/l
2.09
51
212
45
180
2.91
8.36
6.0
4.5
1.68
2.12
mmol/l
0.25
38
136
137
926
2.39
8.18
17.9
9.3
4.61
4.14
e9/l
1.36
130
793
110
687
2.27
7.79
3.6
2.7
—
—
—
0
0
66
336
2.41
7.49
4.2
3.1
2.47
2.46
mmol/l
0.21
60
282
19
46
4.44
7.45
1.3
3.8
58.49
26.16
mg/l
0.87
14
35
19
46
4.44
7.45
1.3
3.8
56.67
84.72
mg/l
0.34
14
35
19
46
4.44
7.45
1.4
1.8
—
—
—
0
0
156
1147
2.42
7.23
5.5
4.2
17.18
13.02
mm/h
2.17
149
1028
36
138
2.94
7.17
1.8
1.6
2.33
1.48
%
2.57
28
121
14
18
8.25
6.73
2.4
1.8
32.07
31.72
pg
0.06
14
18
20
55
3.92
6.65
2.3
2.3
—
—
—
0
0
129
930
2.01
5.56
4.9
3.1
71.84
46.38
u/l
1.36
122
855
52
274
2.20
5.26
2.4
2.0
—
—
—
0
0
148
1133
2.05
5.24
4.9
3.9
15.29
15.01
pmol/l
0.57
137
989
12
20
6.29
4.99
1.4
1.2
173.93
219.36
u/l
0.23
12
20
20
68
3.15
4.86
1.6
2.5
—
—
—
0
0
8
8
10.34
4.56
18.2
14.8
1114.63
1309.25
nmol/l
—
8
8
10
15
6.94
4.52
1.1
1.2
—
—
—
0
0
182
1543
2.39
4.45
41.4
16.2
31.16
25.18
mg/l
1.38
168
1225
168
1384
2.09
4.37
5.9
4.7
2.09
1.96
mu/l
0.49
158
1220
14
43
3.42
3.98
2.7
2.6
16.77
15.55
%
—
9
24
39
204
2.12
3.97
4.5
9.5
1.96
1.40
mmol/l
0.24
27
152
166
1383
1.97
3.87
35.8
15.6
76.75
76.71
ml/min/173m2
0.01
150
1120
11
24
4.78
3.80
4.5
2.8
4.61
4.85
e9/l
0.08
11
24
6
5
12.30
3.78
2.8
1.0
93.33
54.00
nmol/l
—
6
5
14
45
3.26
3.72
1.8
1.9
—
—
—
0
0
14
45
3.26
3.72
2.0
1.3
—
—
—
0
0
9
16
5.82
3.70
1.7
1.6
11.22
13.75
u/l
—
9
16
11
25
4.58
3.68
5.5
2.8
62.73
60.24
%
0.25
11
25
16
58
2.90
3.51
7.4
6.5
1.51
1.50
mg/l
0.02
16
50
36
193
2.05
3.43
2.5
1.8
—
—
—
0
0
14
48
3.05
3.37
1.2
1.3
0.22
0.23
g/l
0.03
14
48
11
28
4.09
3.34
1.0
1.2
—
—
—
0
0
14
49
2.99
3.26
1.2
1.4
1.15
1.15
g/l
0.02
14
49
7
11
6.54
3.21
3.4
1.5
27.71
29.55
umol/l
—
7
11
58
373
1.77
3.18
1.5
1.3
0.75
1.20
u/ml
0.88
24
100
71
489
1.68
3.03
4.5
3.1
0.71
0.39
e6/l
0.57
59
368
53
337
1.77
3.01
5.3
3.6
73.13
280.72
ng/l
1.76
40
274
35
195
1.95
2.99
2.6
1.9
—
—
—
0
0
55
359
1.72
2.84
4.1
2.5
—
—
—
0
0
6
10
6.14
2.71
4.2
2.6
—
—
—
0
0
56
374
1.68
2.64
2.8
2.9
326.16
6324.52
umol/l
1.76
51
306
7
15
4.79
2.62
1.1
1.1
—
—
—
0
0
160
1379
1.68
2.60
5.7
5.9
39.01
40.60
mmol/mol
1.09
148
1259
5
7
7.28
2.56
1.0
1.3
2.38
1.60
mmol/l
—
5
7
7
16
4.49
2.49
4.3
2.6
—
—
—
0
0
20
97
2.17
2.46
2.4
1.8
—
—
—
0
0
8
22
3.74
2.39
1.8
1.2
—
—
—
0
0
27
149
1.93
2.38
3.7
2.1
43.15
29.36
u/l
0.79
27
122
6
13
4.72
2.29
2.3
1.5
4.48
4.48
nmol/l
—
6
13
5
9
5.66
2.22
3.8
2.7
9.20
6.11
%
—
5
9
5
9
5.66
2.22
1.2
1.6
—
—
—
0
0
5
9
5.66
2.22
1.2
1.6
—
—
—
0
0
8
24
3.42
2.20
1.0
1.8
—
—
—
0
0
14
61
2.39
2.20
2.2
2.0
—
—
—
0
0
185
1684
1.86
2.18
55.3
23.5
35.86
39.59
%
9.14
175
1571
9
30
3.09
2.17
1.9
1.7
—
—
—
0
0
6
14
4.38
2.16
1.2
1.1
—
—
—
0
0
9
31
2.99
2.10
1.3
1.5
—
—
—
0
0
8
26
3.16
2.03
1.0
1.8
—
—
—
0
0
10
38
2.71
2.03
1.3
1.7
—
—
—
0
0
14
64
2.27
1.99
2.4
2.3
—
—
—
0
0
6
16
3.83
1.95
1.8
1.6
—
—
—
0
0
5
12
4.24
1.83
1.2
1.6
—
—
—
0
0
5
12
4.24
1.83
1.2
1.6
—
—
—
0
0
9
35
2.64
1.82
1.8
1.3
—
—
—
0
0
7
24
2.98
1.74
1.3
1.8
—
—
—
0
0
7
25
2.86
1.66
1.4
1.3
—
—
—
0
0
153
1362
1.46
1.62
3.8
4.0
1.21
1.26
mmol/l
0.52
137
1216
11
50
2.27
1.60
1.3
1.8
—
—
—
0
0
10
44
2.34
1.58
2.1
2.2
130.00
127.06
g/l
—
10
32
49
357
1.49
1.56
2.4
1.7
1.64
1.16
mg/l
0.75
41
285
9
39
2.37
1.45
1.1
1.4
—
—
—
0
0
9
39
2.37
1.45
1.6
1.5
—
—
—
0
0
5
16
3.17
1.44
1.0
1.3
—
—
—
0
0
19
112
1.77
1.41
2.2
3.2
41.54
62.61
ml/min/173m2
—
8
44
6
23
2.65
1.37
1.7
1.7
—
—
—
0
0
6
23
2.65
1.37
1.7
1.7
—
—
—
0
0
6
23
2.65
1.37
1.7
1.7
—
—
—
0
0
9
42
2.19
1.35
1.4
1.2
—
—
—
0
0
11
54
2.09
1.35
1.3
1.7
—
—
—
0
0
54
423
1.37
1.16
3.8
4.9
2.37
3.45
ug/l
0.49
47
351
7
32
2.23
1.09
1.0
1.3
0.78
0.84
nmol/l
—
7
26
32
233
1.44
1.03
1.3
1.3
16.82
34.13
iu/ml
1.42
11
78
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
9
47
1.96
1.03
5.1
2.6
0.27
0.33
u/ml
—
9
27
156
1440
1.33
0.99
4.3
4.6
5.86
6.02
mmol/l
0.39
140
1284
5
23
2.20
0.98
1.8
1.7
—
—
—
0
0
16
101
1.63
0.97
2.4
2.5
—
16.52
—
0
6
9
51
1.80
0.96
2.2
1.5
—
—
—
0
0
7
37
1.92
0.95
1.4
1.2
—
—
—
0
0
6
27
2.26
0.94
1.0
1.3
—
—
—
0
0
30
386
0.74
0.78
1.6
1.6
1.49
1.33
mmol/l
0.56
23
317
5
24
2.11
0.75
1.8
1.7
—
—
—
0
0
5
24
2.11
0.75
1.8
1.7
—
—
—
0
0
18
251
0.69
0.75
1.9
1.6
—
—
—
0
0
7
38
1.87
0.74
1.3
1.9
—
—
—
0
0
7
38
1.87
0.74
1.3
1.9
—
—
—
0
0
7
39
1.82
0.73
2.0
1.4
—
—
—
0
0
7
39
1.82
0.73
2.0
1.4
—
—
—
0
0
5
26
1.95
0.71
1.4
1.9
—
—
—
0
0
5
26
1.95
0.71
1.4
1.9
—
—
—
0
0
152
1424
1.25
0.70
4.1
4.4
4.26
4.54
mmol/l
2.30
135
1291
13
190
0.66
0.69
1.5
1.4
—
—
—
0
0
150
1414
1.22
0.59
4.0
4.4
1.44
1.49
mmol/l
0.49
135
1272
34
279
1.26
0.54
4.5
2.8
0.96
1.13
e6/l
0.18
23
152
28
224
1.29
0.54
1.4
1.3
1.29
11.97
u/ml
—
10
82
12
83
1.47
0.53
1.8
1.3
416.39
218.29
u/ml
0.27
12
78
13
94
1.41
0.47
6.7
9.2
24.15
24.27
mmol/l
0.03
13
88
5
33
1.53
0.41
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
7
102
0.68
0.40
1.3
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
5
36
1.40
0.38
1.2
1.9
—
—
—
0
0
5
37
1.36
0.37
1.0
1.4
—
2.86
—
0
8
153
1471
1.15
0.36
4.3
5.0
2.40
2.64
mmol/l
2.26
139
1324
23
191
1.23
0.35
12.6
9.6
—
—
—
0
0
6
45
1.34
0.34
1.2
1.1
—
—
—
0
0
15
187
0.79
0.33
3.4
4.6
43.89
32.49
%
—
9
115
94
889
1.10
0.26
2.8
2.9
—
—
—
0
0
21
244
0.85
0.25
2.1
3.1
2.01
0.87
ug/l
0.54
15
160
5
40
1.26
0.22
1.0
1.9
0.70
2.90
mg/l
—
5
26
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
49
455
1.10
0.20
3.6
3.7
18.42
8.84
mg/mmol
0.47
34
278
7
58
1.21
0.18
1.3
1.2
—
—
—
0
0
7
58
1.21
0.18
2.0
1.8
—
—
—
0
0
6
78
0.76
0.16
1.2
1.0
—
—
—
0
0
11
126
0.87
0.11
1.5
2.3
—
—
—
0
0
31
330
0.93
0.10
3.9
4.4
21.20
21.60
%
0.05
16
156
5
48
1.04
0.09
2.4
1.9
—
—
—
0
0
11
112
0.98
0.00
1.3
2.1
—
—
—
0
0
6
59
1.02
0.00
1.3
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
8.00
—
0
7
8
85
0.94
-0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.34
—
0
5
5
52
0.96
-0.00
2.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_PROTMALNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PROTMALNAS | 2.983 [1.98, 4.5] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.849 |
During the follow-up period (1.1.1998 — 31.12.2019), 423 out of 1180 females with E4_PROTMALNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PROTMALNAS | 4.251 [2.36, 7.66] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.108 |
During the follow-up period (1.1.1998 — 31.12.2019), 339 out of 773 males with E4_PROTMALNAS died.
Mortality risk
Mortality risk for people of age
years, who have E4_PROTMALNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.239% | 1.022% |
| 5 | 1.836% | 5.449% |
| 10 | 5.126% | 13.589% |
| 15 | 9.269% | 24.479% |
| 20 | 16.303% | 39.043% |
Relationships between endpoints
↥Index endpoint: E4_PROTMALNAS – Unspecified protein-energy malnutrition
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data